Pura Vida Investments, LLC Eli Lilly & CO Put Options Transaction History

Pura Vida Investments, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $2.32 Million - $2.88 Million	3,000 New	3,000 $2.66 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $20.5 Million - $24.6 Million	-150,000 Closed	0 $0
Q1 2020 Feb 12, 2021	BUY	$119.05 - $147.35 $17.7 Million - $21.9 Million	148,500 Added 9900.0%	150,000 $20.8 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $178,575 - $221,025	1,500 New	1,500 $587,000

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $750B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Pura Vida Investments, LLC with notifications on news.